FindTrial
Sign In

A multicenter, double-blind, randomized, self-opposite control study for comapring IPL vs. ResurFx for enlarged facial pores

A multicenter, double-blind, randomized, self-opposite control study for comapring IPL vs. ResurFx for enlarged facial pores

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009874
Enrollment
Unknown
Registered
2016-11-15
Start date
2016-11-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial pore

Interventions

self-opposite control:IPL vs 1565nm ANFL

Sponsors

Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. conform to the patients with facial pore; 2. aged > 14 years old; 3. did not receive any other laser or injection a period of 6 months. 4. signed a consent form.

Exclusion criteria

Exclusion criteria: 1. laser contraindications; 2. local ulcers, infections, eczema lesions; 3. scar constitution; 4. pregnancy, nursing mothers; 5. for nearly three months had a history of sun exposure; 6. the patient is not willing to accept or not adhere during the treatment.

Design outcomes

Primary

MeasureTime frame
the quantity of facial pores;—

Countries

China

Contacts

Public ContactXiaoxi Lin

Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine

860382817@qq.com+86 15618690545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026